Genome-Wide Expression Analysis of a Spinal Muscular Atrophy Model: Towards Discovery of New Drug Targets
2008

Gene Expression Changes in a Spinal Muscular Atrophy Model

Sample size: 3 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lee Sheena, Sayin Arzu, Grice Stuart, Burdett Howard, Baban Dilair, van den Heuvel Marcel

Primary Institution: University of Oxford

Hypothesis

How does reduced SMN activity affect gene expression in a model of spinal muscular atrophy?

Conclusion

The study identifies gene expression changes in a fly model of spinal muscular atrophy that could lead to new drug targets.

Supporting Evidence

  • Gene expression changes were validated using standard methods.
  • Identified genes show trends consistent with the function of SMN.
  • Some identified genes could be potential drug targets for SMA.

Takeaway

Scientists studied fruit flies to see how a gene related to a disease affects other genes, hoping to find new ways to help people with that disease.

Methodology

The study used whole genome micro-arrays to analyze gene expression in control and diseased fly tissues.

Limitations

The study is limited by the small amount of tissue available from Drosophila and the complexity of genetic interactions.

Participant Demographics

The study used Drosophila melanogaster (fruit flies) as a model organism.

Statistical Information

P-Value

≤0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001404

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication